Earningsreport

Q2/2023 6/30/2023 EPS 0.050 ZacksConsensus -0.160 ActVsEst 0.210 - Beat

Pieris Pharmaceuticals, Inc.  (PIRS) 
NASDAQ:AMEX Investor Relations: ir.pieris.com